<DOC>
	<DOCNO>NCT01325389</DOCNO>
	<brief_summary>Menopause milestone broaden condition last 10 year . The first menopausal symptom usually appear around age 42 characterize gradual decline thyroid gonadal function progressive increase plasmatic luteinizing hormone ( LH ) follicle stimulate hormone ( FSH ) level . Recent study show myo-inositol melatonin play major role ovarian homeostasis . In particular , demonstrate myo-inositol and/or melatonin supplementation lead increase oocyte quality . Additional study focus postmenopausal woman show myo-inositol able ameliorate metabolic syndrome often affect patient , thus reduce risk cardiovascular disease ( CVDs ) . The aim present study evaluate whether myo-inositol melatonin might play positive role regulate hormonal level menopausal onset .</brief_summary>
	<brief_title>Myo-inositol Plus Melatonin Perimenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Inositol</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>FSH 15 50 IU/ml 5th day menses Oligomenorrhea</criteria>
	<gender>Female</gender>
	<minimum_age>42 Years</minimum_age>
	<maximum_age>48 Years</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>